Ignite Creation Date:
2025-12-24 @ 3:07 PM
Ignite Modification Date:
2025-12-25 @ 4:55 PM
Study NCT ID:
NCT04652492
Status:
UNKNOWN
Last Update Posted:
2020-12-03
First Post:
2020-11-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma
Sponsor:
Zhongda Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BGB-A317-2004-IIT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None